Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v1-EN
Language French English
Date Updated 2020-01-06 2019-09-25
Drug Identification Number 02057778 02057778
Brand name PLENDIL 2.5 MG PLENDIL 2.5 MG
Common or Proper name felodipine felodipine
Company Name GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
Ingredients FELODIPINE FELODIPINE
Strength(s) 2.5MG 2.5MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 tablets 1 x 30
ATC code C08CA C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-10-10 2019-10-10
Actual start date 2019-10-10
Estimated end date 2020-01-06 2019-12-13
Actual end date 2020-01-02
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Manufacturing constraints Manufacturing constraints
Health Canada comments